Acute zonal occult outer retinopathy and central nervous system inflammation

Journal of Neuro-Ophthalmology

Volumn 16, Issue 3, 1996, Pages 172-177

  Jacobson, Daniel M ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Electroretinography; Multiple sclerosis; Photopsia; Retinopathy; Scotoma

Indexed keywords

EID: 85013761111     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/00041327-199609000-00002     Document Type: Article

References (31)

1. Gass JDM. Acute zonal occult outer retinopathy. Donders lecture: the Netherlands Ophthalmology Society, Maastricht, Holland, June 19, 1992. J Clin Neuro Ophthalmol 1993; 13: 79-97.
2. Gass JDM, Stern C. Acute annular outer retinopathy as a variant of acute zonal occult outer retinopathy. Am J Ophthalmol 1995; 119: 330-4.
3. Holz FG, Kim RY, Schwartz SD, et al. Acute zonal occult outer retinopathy (AZOOR) associated with multifocal choroidopathy. Eye 1994; 8: 77-83.
4. Marmor MF, Arden GB, Nilsson SE, Zrenner E. Standard for clinical electroretinography. Arch Ophthalmol 1989; 107: 816-9.
5. Marmor MF, Zrenner E. Standard for electro-oculography. Arch Ophthalmol 1993; 111: 601-4.
6. Kesselring J, Ormerod IEC, Miller DH, du Boulay EPGH, McDonald WI. Magnetic resonance imaging in multiple sclerosis. New York: Thieme Medical, 1989: 40-62.
7. Christenson RH, Behlmer P, Howard JF, Winfield JB, Silverman LM. Interpretation of cerebrospinal fluid protein assays in various neurological diseases. Clin Chem 1983; 29: 1028-30.
8. Miller DH, Kendall BE, Barter S, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988; 38: 378-83.
9. Scott TF, Seay AR, Goust JM. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis. Neurology 1989; 39: 1637-9.
10. Stimmler MM, Coletti PM, Quismorio FP. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 335-49.
11. Kelly MC, Donburg JA. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J Rheumatol 1987; 14: 740-4.
12. Rose AS, Ellison GW, Myers LW, Tourtellotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976; 26: 20-2.
13. Schumacher CA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann NY Acad Sei 1965; 122: 552-68.
14. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
15. Isaac G, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MR1 in relapsing patients. Neurology 1988; 38: 1511-5.
16. Willoughby EW, Grochowski E, Li DKB, Ogei J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989; 25: 43-9.
17. Truyen L, Gheuens J, Parizel PM, Van de Vyver FL, Martin JJ. Long term follow-up of multiple sclerosis by standardized, non-contrast-enhanced magnetic resonance imaging. J Neurol Sei 1991; 106: 35-40.
18. Mattson DH, Roos RP, Arnason BGH. Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol 1981; 9: 34-41.
19. Tourtellotte WW, Walsh MJ. Cerebrospinal fluid profile in multiple sclerosis. In: Poser CM, Paty DW, Scheinberg L, McDonald WI, Ebers GC, eds. The diagnosis of multiple sclerosis. New York: Thieme-Stratton, 1984: 165-78.
20. Compston A. Genetic factors in the aetiology of multiple sclerosis. In: McDonald WI, Silberberg DH, eds. Multiple sclerosis. Boston: Butterworth, 1986: 56-73.
21. Gass JDM. Acute posterior multifocal placoid pigment ep-itheliopathy. Arch Ophthalmol 1968; 80: 177-85.
22. Weinstein JM, Bresnick GH, Bell CL, Roschmann RA, Brooks BR, Strother CM. Acute posterior multifocal placoid pigment epitheliopathy associated with cerebral vasculitis. J Clin Neuro Ophthalmol 1988; 8: 195-201.
23. Wilson CA, Choromokos EA, Sheppard R. Acute posterior multifocal placoid pigment epitheliopathy and cerebral vasculitis. Arch Ophthalmol 1988; 106: 796-800.
24. Stoll G, Reiners K, Schwartz A, Kaup FG, Althaus C, Freund HJ. Acute posterior multifocal placoid pigment epitheliopathy with cerebral involvement. J Neurol Ncitrosttro Psychiatry 1991; 54: 77-9.
25. Althaus C, Unsold R, Figge C, Sundmacher R. Cerebral complications in acute posterior multifocal placoid pigment epitheliopathy. German J Ophthalmol 1993; 2: 150-4.
26. Kersten DH, Lessell S, Carlow TJ. Acute posterior multifocal placoid pigment epitheliopathy and late-onset meningoencephalitis. Ophthalmology 1987; 94: 393-6.
27. Graham EM, Francis DA, Sanders MD, Rudge P. Ocular inflammatory changes in established multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 1360-3.
28. Lim JI, Tessler HH, Goodwin JA. Anterior granulomatous uveitis in patients with multiple sclerosis. Ophthalmology 1991; 98: 142-5.
29. Malinowski SM, Pulido JS, Folk JC. Long-term visual complications associated with pars planitis. Ophthalmology 1993; 100: 818-25.
30. Bamford CR, Ganley JP, Sibley WA, Laguna JF. Uveitis, perivenous sheathing and multiple sclerosis. Neurology 1978; 28: 119-24.
31. Younge BR. Fluorescein angiography and retinal venous sheathing in multiple sclerosis. Can J Ophthalmol 1976; 11: 31-6.